Clinical trialNCT01590472CompletedObservational

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma

SponsorWake Forest UniversityEnrollment69Mesothelioma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this research study is to investigate the possibility that a person's genes put a person at a higher risk of developing mesothelioma. The investigators will examine genes from DNA (genetic material) isolated from blood. This study will also examine the impact of environmental and work exposures and family history of common cancers on the development of mesothelioma. The genetic markers in this study will basically identify how a person's body processes frequently encountered environmental pollutants and will not tell about chromosomes, specific diseases, or other potential health problems.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel H Sterman, MD
University of Pennsylvania
Principal Investigator
clinicaltrials.gov ↗
Harvey I Pass, MD
NYU Langone Health
Principal Investigator
clinicaltrials.gov ↗
Jill Ohar, MD
Wake Forest University
Study Director
clinicaltrials.gov ↗
Julie Brahmer, MD
Johns Hopkins University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Lee Krug, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Tobias Peikert, MD
Mayo Clinic
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Johns Hopkins University
Baltimore, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
New York University School of Medicine
New York, New York, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2011
Primary completion: 31 Dec 2014
Completion: 31 Dec 2015
Last update posted: 7 Nov 2017
Registered enrollment: 69
Registry id: NCT01590472

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.